Literature DB >> 27886903

Allergic Contact Dermatitis.

Lisa Kostner1, Florian Anzengruber1, Caroline Guillod1, Mike Recher2, Peter Schmid-Grendelmeier1, Alexander A Navarini3.   

Abstract

Allergic contact dermatitis (ACD) is a common skin disease caused by a T cell-mediated immune reaction to usually innocuous allergens. ACD can have grave medical and socioeconomic consequences. ACD and irritant contact dermatitis often occur together. A detailed history and clinical examination are crucial and guide patch testing, which is the gold standard to diagnose ACD. T-cell clones persisting in the skin may explain the tendency of ACD to relapse even after years of allergen avoidance. Traditional treatments for ACD are topical steroids, calcineurin inhibitors, phototherapy, retinoids (including the recent alitretinoin), and immunosuppressants. Targeted therapies are lacking. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergen; Contact; Dermatitis; Patch; T cell; Work related

Mesh:

Substances:

Year:  2017        PMID: 27886903     DOI: 10.1016/j.iac.2016.08.014

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  17 in total

1.  Involvement of the Negative Feedback of IL-33 Signaling in the Anti-Inflammatory Effect of Electro-acupuncture on Allergic Contact Dermatitis via Targeting MicroRNA-155 in Mast Cells.

Authors:  Zhigang Wang; Tao Yi; Man Long; Fengmin Ding; Lichen Ouyang; Zebin Chen
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

2.  Activation of Mast-Cell-Expressed Mas-Related G-Protein-Coupled Receptors Drives Non-histaminergic Itch.

Authors:  James Meixiong; Michael Anderson; Nathachit Limjunyawong; Mark F Sabbagh; Eric Hu; Madison R Mack; Landon K Oetjen; Fang Wang; Brian S Kim; Xinzhong Dong
Journal:  Immunity       Date:  2019-04-23       Impact factor: 31.745

3.  High Frequency of Dermatological Complications in Children and Adolescents with Type 1 Diabetes: A Web-Based Survey.

Authors:  Fortunato Lombardo; Stefano Passanisi; Davide Tinti; Maria Francesca Messina; Giuseppina Salzano; Ivana Rabbone
Journal:  J Diabetes Sci Technol       Date:  2020-08-06

4.  Bacitracin: A Causative Agent of Purpuric Allergic Contact Dermatitis.

Authors:  Aysegul Ertugrul; Emrah Utku Kabatas
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2020-12       Impact factor: 0.885

Review 5.  The Dendritic Cell Dilemma in the Skin: Between Tolerance and Immunity.

Authors:  Nils Scheib; Jessica Tiemann; Christian Becker; Hans Christian Probst; Verena Katharina Raker; Kerstin Steinbrink
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

6.  TRPC3 Antagonizes Pruritus in a Mouse Contact Dermatitis Model.

Authors:  Katherine Beattie; Haowu Jiang; Mayank Gautam; Mary K MacVittie; Barbara Miller; Minghong Ma; Qin Liu; Wenqin Luo
Journal:  J Invest Dermatol       Date:  2021-09-25       Impact factor: 7.590

Review 7.  Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease.

Authors:  Saptarshi Roy; Chalatip Chompunud Na Ayudhya; Monica Thapaliya; Vishwa Deepak; Hydar Ali
Journal:  J Allergy Clin Immunol       Date:  2021-05-04       Impact factor: 14.290

8.  Impact of Allergic Contact Dermatitis on the Quality of Life and Work Productivity.

Authors:  H Kalboussi; I Kacem; H Aroui; O El Maalel; M Maoua; A Brahem; S El Guedri; S Chatti; N Ghariani; N Mrizak
Journal:  Dermatol Res Pract       Date:  2019-03-03

9.  Cutaneous reactions caused by nitrofurazone.

Authors:  Serap Gunes Bilgili; Goknur Ozaydin-Yavuz; Ibrahim Halil Yavuz; Mehmet Ali Bilgili; Ayse Serap Karadag
Journal:  Postepy Dermatol Alergol       Date:  2019-08-30       Impact factor: 1.837

10.  Self-Reported Prevalence of Allergies in the USA and Impact on Skin-An Epidemiological Study on a Representative Sample of American Adults.

Authors:  Sophie Seité; Alyce Mei-Shiuan Kuo; Charles Taieb; Tamara Lazić Strugar; Peter Lio
Journal:  Int J Environ Res Public Health       Date:  2020-05-12       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.